New MRI scan could spot liver cancer earlier in High-Risk patients
NCT ID NCT06658782
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether a 20-minute MRI scan without dye can detect liver cancer earlier than the usual ultrasound in 300 people with cirrhosis who are at high risk. Participants will get both scans every 6 months for 30 months. The goal is to see if the MRI catches cancers that ultrasound might miss, while being safer and cheaper than contrast scans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
non-contrast magnetic resonance imaging (MRI) scan
What this could lead to
If successful, this could offer a safer, more accurate way to spot liver cancer early in people with cirrhosis, potentially saving more lives.
What could go wrong
This is a feasibility study with only 300 participants. The MRI may not prove better than ultrasound in practice, and results may not apply to all groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bournemouth University Hospital
RECRUITINGBournemouth, United Kingdom
-
Oxford University Hospitals NHS Foundation Trudt
RECRUITINGOxford, Oxon, ox3 9du, United Kingdom
Contact
Contact Email: •••••@•••••